Skip to content
Journal article

Opioid receptors in the gastrointestinal tract

Holzer P...(+1 more)
  • 1

    Readers

    Mendeley users who have this article in their library.
  • N/A

    Citations

    Citations of this article.
  • N/A

    Views

    ScienceDirect users who have downloaded this article.
Sign in to save reference

Abstract

Opium is arguably one of the oldest herbal medicines, being used as analgesic, sedative and antidiarrheal drug for thousands of years. These effects mirror the actions of the endogenous opioid system and are mediated by the principal mu-, kappa- and delta-opioid receptors. In the gut, met-enkephalin, leu-enkephalin, beta-endorphin and dynorphin occur in both neurons and endocrine cells. When released, opioid peptides activate opioid receptors on the enteric circuitry controlling motility and secretion. As a result, inhibition of gastric emptying, increase in sphincter tone, induction of stationary motor patterns and blockade of peristalsis ensue. Together with inhibition of ion and fluid secretion, these effects cause constipation, one of the most frequent and troublesome adverse reactions of opioid analgesic therapy. Although laxatives are most frequently used to ameliorate opioid-induced bowel dysfunction, their efficacy is unsatisfactory. Specific antagonism of peripheral opioid receptors is a more rational approach. This goal is addressed by the use of opioid receptor antagonists with limited absorption such as oral prolonged-release naloxone and opioid receptor antagonists that do not penetrate the blood-brain barrier such as methylnaltrexone and alvimopan. Preliminary evidence indicates that peripherally restricted opioid receptor antagonists may act as prokinetic drugs in their own right.

Author-supplied keywords

  • Animals
  • Constipation/chemically induced
  • Gastrointestinal Tract/*drug effects
  • Humans
  • Naloxone/adverse effects/pharmacology
  • Naltrexone/adverse effects/analogs & derivatives/p
  • Narcotic Antagonists/*adverse effects/pharmacology
  • Piperidines/adverse effects/pharmacology
  • Quaternary Ammonium Compounds/adverse effects/phar
  • Receptors, Opioid/*antagonists & inhibitors/metabo

Cite this document

Choose a citation style from the tabs below